ClinicalTrials.Veeva

Menu

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring (CARDS-pilot)

Q

Qompium

Status

Enrolling

Conditions

Atrial Fibrillation

Treatments

Device: FibriCheck recordings

Study type

Interventional

Funder types

Industry

Identifiers

NCT06422468
Z-2023103

Details and patient eligibility

About

The goal of this interventional clinical trial is to investigate whether combining photoplethysmography (PPG) signals with accelerometer (ACC), gyroscope (GYR), sound, and electrocardiography (ECG) derived smartphone data provides additional insights into the cardiac condition of individuals with and without atrial fibrillation (AF).

Enrollment

125 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Inclusion criteria applicable for all groups:

  • At least 18 years old
  • Participants must have the ability to understand and provide written informed consent
  • Participants must have the ability to understand Dutch

Group specific inclusion criteria:

Group 1: Healthy volunteers

  • No cardiac conditions based on medical history.

Group 2: Cardiology patients

  • Patients at the consultation or ambulatory unit of Cardiology (pre- cardioversion, pre-pulmonary vein isolation) with AF.
  • Patients without AF but with a current cardiac condition (e.g. heart failure with a reduced or preserved ejection fraction) or a history of a cardiac condition (e.g. history of myocardial infarction).

Exclusion criteria

  • Individuals with unnaturally coloured fingers (i.e. tattoos, ink); this may weaken the signal and may interfere with the effectiveness of the device
  • Persons with conditions causing tremors or the inability to hold their hand still for at least 60 seconds (e.g. Parkinson or dementia) as, in this case, the device may not be able to accurately process a measurement
  • Persons with reduced blood flow in the fingertips (e.g. perniosis or severe callus formation) as the device may not be able to detect the intensity variations induced by the blood flow
  • Persons that have a disability to perform the measurements according to the instructions for use
  • Persons with cardiac pacemakers, implantable cardioverter-defibrillators, or other implanted electronic devices as these can control the natural heart rhythm

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

125 participants in 1 patient group

FibriCheck recordings
Other group
Treatment:
Device: FibriCheck recordings

Trial contacts and locations

1

Loading...

Central trial contact

Lars Grieten, PhD; Annelies Geeraerts, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems